Pemphigus vegetans possible association with enalapril

Paulina Barasińska; Natalia Noga; Beata S. Bergler-Czop; Jakub Sazanów-Lubelski; Kornelia Pietrauszka; Ligia Brzezińska-Wcisło

doi:10.5114/dr.2019.86915

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2019
vol. 106

Send email

Copy url:

abstract:

Case report

Pemphigus vegetans possible association with enalapril

Paulina Barasińska

¹

,

Natalia Noga

¹

,

Beata S. Bergler-Czop

²

,

Jakub Sazanów-Lubelski

¹

,

Kornelia Pietrauszka

³

,

Ligia Brzezińska-Wcisło

²

Dermatology and STD Ward, Municipal Hospital, Sosnowiec, Poland
Department of Dermatology, Medical Faculty in Katowice, Silesian Medical University in Katowice, Poland
The Student’s Science Club by the Department of Dermatology, Medical University in Katowice, Poland

Dermatol Rev/Przegl Dermatol 2019, 106, 321–329

DOI: https://doi.org/10.5114/dr.2019.86915

Online publish date: 2019/08/24

View full text Get citation

PlumX metrics:

Introduction
Pemphigus vegetans is the least common form of pemphigus. Typical clinical presentation of the condition involves blisters transforming into papillous or pustular eruptions. Treatment consists of administration of systemic glucocorticosteroids as a monotherapy, or combined with immunosuppressants.

Objective
Presentation of a case of pemphigus vegetans of possible drug-induced aetiology and severe course.

Case Report
A 58-year old man was admitted with papillous lesions persisting for few weeks in the anogenital area, axillae and ear lobes. For several months the man has been using the hypotensive medication – enalapril. Pemphigus vegetans was diagnosed based on the clinical presentation and the immunopathological examination. Enalapril was discontinued and prednisone was introduced at the maximum dose of 2 mg/kg/day, with subsequent improvement of the condition. Considering adverse effects of chronic glucocorticosteroid therapy, azathioprin was also introduced at the dose of 50 mg/day, with gradual reduction of the prednisone dose over time. The patient in good general and local condition remains under supervision of a dermatologist.

Conclusions
A case of a patient is presented with lesions initially suggesting papillary pyroderma. As a result of rapid progression the disease significantly hindered the patient’s everyday functioning. Pemphigus vegetans in this patient may have been induced by enalapril.

keywords:

Pemphigus vegetans possible association with enalapril

Paulina Barasińska 1 , Natalia Noga 1 , Beata S. Bergler-Czop 2 , Jakub Sazanów-Lubelski 1 , Kornelia Pietrauszka 3 , Ligia Brzezińska-Wcisło 2

autoimmune diseases, azathioprin, pemphigus vegetans, desmoglein

Paulina Barasińska

¹

,

Natalia Noga

¹

,

Beata S. Bergler-Czop

²

,

Jakub Sazanów-Lubelski

¹

,

Kornelia Pietrauszka

³

,

Ligia Brzezińska-Wcisło

²